Daniel Fuster

1.6k total citations
66 papers, 1.0k citations indexed

About

Daniel Fuster is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Daniel Fuster has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 29 papers in Pathology and Forensic Medicine and 29 papers in Hepatology. Recurrent topics in Daniel Fuster's work include Liver Disease Diagnosis and Treatment (30 papers), Alcohol Consumption and Health Effects (28 papers) and Hepatitis C virus research (26 papers). Daniel Fuster is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Alcohol Consumption and Health Effects (28 papers) and Hepatitis C virus research (26 papers). Daniel Fuster collaborates with scholars based in Spain, United States and Russia. Daniel Fuster's co-authors include Jeffrey H. Samet, Roberto Muga, Jordi Tor, Arantza Sanvisens, Bonaventura Clotet, Ferrán Bolao, Cristina Tural, Celestino Rey‐Joly, Ramón Planas and Debbie M. Cheng and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Hepatology.

In The Last Decade

Daniel Fuster

64 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Fuster Spain 19 658 451 303 199 93 66 1.0k
Eugènia Mariné–Barjoan France 13 442 0.7× 302 0.7× 65 0.2× 82 0.4× 25 0.3× 26 769
Paolo Mezzelani Italy 18 506 0.8× 334 0.7× 38 0.1× 64 0.3× 23 0.2× 49 907
Chris Corbett United Kingdom 14 235 0.4× 150 0.3× 77 0.3× 73 0.4× 21 0.2× 27 746
Ari Illeperuma United States 7 857 1.3× 588 1.3× 26 0.1× 133 0.7× 9 0.1× 13 1.2k
G Belloni Italy 13 371 0.6× 397 0.9× 34 0.1× 34 0.2× 42 0.5× 34 677
Goran Hauser Croatia 20 667 1.0× 505 1.1× 37 0.1× 50 0.3× 22 0.2× 62 1.2k
G. Masterton United Kingdom 15 387 0.6× 125 0.3× 52 0.2× 36 0.2× 37 0.4× 50 792
Shirley Huang United States 9 843 1.3× 811 1.8× 45 0.1× 44 0.2× 12 0.1× 19 1.2k
M Youle United Kingdom 14 186 0.3× 23 0.1× 34 0.1× 432 2.2× 170 1.8× 35 665
Rajiv R. Varma United States 12 794 1.2× 835 1.9× 23 0.1× 39 0.2× 14 0.2× 27 1.2k

Countries citing papers authored by Daniel Fuster

Since Specialization
Citations

This map shows the geographic impact of Daniel Fuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Fuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Fuster more than expected).

Fields of papers citing papers by Daniel Fuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Fuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Fuster. The network helps show where Daniel Fuster may publish in the future.

Co-authorship network of co-authors of Daniel Fuster

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Fuster. A scholar is included among the top collaborators of Daniel Fuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Fuster. Daniel Fuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuster, Daniel, et al.. (2024). Substance use disorder: Epidemiology, medical consequences and treatment. Medicina Clínica (English Edition). 162(9). 431–438. 2 indexed citations
2.
Fuster, Daniel, et al.. (2024). Trastorno por uso de sustancias: epidemiología, complicaciones médicas y tratamiento. Medicina Clínica. 162(9). 431–438. 8 indexed citations
3.
Muga, Roberto, et al.. (2024). Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction Science & Clinical Practice. 19(1). 19–19. 10 indexed citations
4.
Fuster, Daniel, Laia Miquel, Marta Torrens, et al.. (2024). Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder. Alcohol Clinical and Experimental Research. 48(7). 1313–1321. 3 indexed citations
5.
Muga, Roberto, et al.. (2024). Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder. Nutrients. 16(8). 1099–1099. 1 indexed citations
6.
Hernández, Ainhoa, Eudald Felip, Marc Cucurull, et al.. (2022). Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study. Cancers. 15(1). 137–137. 4 indexed citations
7.
Poyatos, Lourdes, Esther Papaseit, Clara Pérez‐Mañá, et al.. (2022). Abuse Potential of Cathinones in Humans: A Systematic Review. Journal of Clinical Medicine. 11(4). 1004–1004. 15 indexed citations
8.
Teniente‐Serra, Aina, et al.. (2022). Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. Journal of Clinical Medicine. 11(2). 305–305. 8 indexed citations
9.
Fuster, Daniel, et al.. (2021). Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder. Journal of Clinical Medicine. 10(16). 3496–3496. 2 indexed citations
10.
Fuster, Daniel, et al.. (2020). Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence. 216. 108231–108231. 1 indexed citations
11.
Sanvisens, Arantza, Gabriel Rubio, Antoni Gual, et al.. (2020). Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder. Journal of Addiction Medicine. 15(1). 68–73. 7 indexed citations
12.
Bolao, Ferrán, et al.. (2019). Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL‐6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcoholism Clinical and Experimental Research. 44(1). 152–158. 10 indexed citations
13.
Muga, Roberto, Arantza Sanvisens, Inmaculada Jarrín, et al.. (2018). Hepatitis C infection substantially reduces survival of alcohol-dependent patients. Clinical Epidemiology. Volume 10. 897–905. 8 indexed citations
14.
Fuster, Daniel, et al.. (2018). Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Drug and Alcohol Dependence. 190. 195–199. 7 indexed citations
15.
Sanvisens, Arantza, Daniel Fuster, Ferrán Bolao, et al.. (2017). Folate deficiency in patients seeking treatment of alcohol use disorder. Drug and Alcohol Dependence. 180. 417–422. 18 indexed citations
16.
Sanvisens, Arantza, Aina Teniente‐Serra, Daniel Fuster, et al.. (2016). Wide array of T-cell subpopulation alterations in patients with alcohol use disorders. Drug and Alcohol Dependence. 162. 124–129. 8 indexed citations
17.
Fuster, Daniel, Judith I. Tsui, Debbie M. Cheng, et al.. (2013). Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Research and Human Retroviruses. 29(8). 1110–1116. 18 indexed citations
18.
Solà, Ricard, Silvia Montoliu, Cristina Tural, et al.. (2006). Poor Response to Hepatitis C Virus (HCV) Therapy in HIV- and HCV-Coinfected Patients Is Not Due to Lower Adherence to Treatment. AIDS Research and Human Retroviruses. 22(5). 393–400. 20 indexed citations
19.
Fuster, Daniel, Ramón Planas, Roberto Muga, et al.. (2004). Advanced Liver Fibrosis in HIV/HCV-Coinfected Patients on Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(12). 1293–1297. 44 indexed citations
20.
Tural, Cristina, Daniel Fuster, Jordi Tor, et al.. (2003). Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients. Journal of Viral Hepatitis. 10(2). 118–125. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugènia Mariné–Barjoan Breakdown of academic impact, for papers by Paolo Mezzelani Breakdown of academic impact, for papers by Chris Corbett Breakdown of academic impact, for papers by Ari Illeperuma Breakdown of academic impact, for papers by G Belloni Breakdown of academic impact, for papers by Goran Hauser Breakdown of academic impact, for papers by G. Masterton Breakdown of academic impact, for papers by Shirley Huang Breakdown of academic impact, for papers by M Youle Breakdown of academic impact, for papers by Rajiv R. Varma
Rankless by CCL
2026